Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2018

01-12-2018 | ASO Author Reflections

ASO Author Reflections: Quality of Life After HIPEC for Pseudomyxoma Peritonei

Authors: Adam T. Stearns, MA, DPhil, FRCS, Sarah T. O’Dwyer, MD, FRCS

Published in: Annals of Surgical Oncology | Special Issue 3/2018

Login to get access

Excerpt

Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) is the standard of care for patients with pseudomyxoma peritonei (PMP), conferring long-term survival or cure. This experience has acted as a model for other peritoneal metastases, including ovarian, colorectal, and highly selected gastric cancers, although the survival benefit of nonappendiceal primaries varies and remains the subject of further evaluation.1,2 …
Literature
1.
Seretis C, Youssef H. Quality of life after cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: a systematic review. Eur J Surg Oncol. 2014;40(12):1605–13.CrossRefPubMed
2.
Dodson RM, McQuellon RP, Mogal HD, et al. Quality-of-life evaluation after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23(Suppl 5):772–83.CrossRefPubMedCentralPubMed
3.
Stearns AT, Malcomson L, Punnett G, et al. Long-term quality of life after cytoreductive surgery and heated intraperitoneal chemotherapy for pseudomyxoma peritonei: a prospective longitudinal study. Ann Surg Oncol. 2018;25(4):965–73.CrossRefPubMed
4.
Hinz A, Singer S, Brahler E. European reference values for the quality of life questionnaire EORTC QLQ-C30: results of a German investigation and a summarizing analysis of six European general population normative studies. Acta Oncol. 2014;53(7):958–65.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Quality of Life After HIPEC for Pseudomyxoma Peritonei
Authors
Adam T. Stearns, MA, DPhil, FRCS
Sarah T. O’Dwyer, MD, FRCS
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6898-3

Other articles of this Special Issue 3/2018

Annals of Surgical Oncology 3/2018 Go to the issue

ASO Author Reflections

ASO Author Reflections: African Americans and Rectal Cancer Surgery

ASO Author Reflections

ASO Author Reflections: The Role of Tumor Size in the Prognosis of Anal Squamous Cell Carcinoma: A Validation on the New American Joint Committee on Cancer Subclassification of Stage IIA and B

ASO Author Reflections

ASO Author Reflections: Postoperative Chylothorax After Radical Subtotal Esophagectomy

ASO Author Reflections

ASO Author Reflections: PCI is Not Predictive of Survival After Complete CRS/HIPEC for High-Grade Appendiceal Primaries

ASO Author Reflections

ASO Author Reflections: Acellular Dermal Matrix Reduces Myofibroblasts in Capsule Tissue

ASO Author Reflections

ASO Author Reflections: Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors